Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma
Shaoshuai Tang,
Yunzhi Wang,
Rongkui Luo,
Rundong Fang,
Yufeng Liu,
Hang Xiang,
Peng Ran,
Yexin Tong,
Mingjun Sun,
Subei Tan,
Wen Huang,
Jie Huang,
Jiacheng Lv,
Ning Xu,
Zhenmei Yao,
Qiao Zhang,
Ziyan Xu,
Xuetong Yue,
Zixiang Yu,
Sujie Akesu,
Yuqin Ding,
Chen Xu (),
Weiqi Lu (),
Yuhong Zhou (),
Yingyong Hou () and
Chen Ding ()
Additional contact information
Shaoshuai Tang: Fudan University
Yunzhi Wang: Fudan University
Rongkui Luo: Fudan University
Rundong Fang: Fudan University
Yufeng Liu: Fudan University
Hang Xiang: Fudan University
Peng Ran: Fudan University
Yexin Tong: Fudan University
Mingjun Sun: Fudan University
Subei Tan: Fudan University
Wen Huang: Fudan University
Jie Huang: Fudan University
Jiacheng Lv: Fudan University
Ning Xu: Fudan University
Zhenmei Yao: Fudan University
Qiao Zhang: Fudan University
Ziyan Xu: Fudan University
Xuetong Yue: Fudan University
Zixiang Yu: Fudan University
Sujie Akesu: Fudan University
Yuqin Ding: Fudan University
Chen Xu: Fudan University
Weiqi Lu: Fudan University
Yuhong Zhou: Fudan University
Yingyong Hou: Fudan University
Chen Ding: Fudan University
Nature Communications, 2024, vol. 15, issue 1, 1-24
Abstract:
Abstract Soft tissue sarcoma is a broad family of mesenchymal malignancies exhibiting remarkable histological diversity. We portray the proteomic landscape of 272 soft tissue sarcomas representing 12 major subtypes. Hierarchical classification finds the similarity of proteomic features between angiosarcoma and epithelial sarcoma, and elevated expression of SHC1 in AS and ES is correlated with poor prognosis. Moreover, proteomic clustering classifies patients of soft tissue sarcoma into 3 proteomic clusters with diverse driven pathways and clinical outcomes. In the proteomic cluster featured with the high cell proliferation rate, APEX1 and NPM1 are found to promote cell proliferation and drive the progression of cancer cells. The classification based on immune signatures defines three immune subtypes with distinctive tumor microenvironments. Further analysis illustrates the potential association between immune evasion markers (PD-L1 and CD80) and tumor metastasis in soft tissue sarcoma. Overall, this analysis uncovers sarcoma-type-specific changes in proteins, providing insights about relationships of soft tissue sarcoma.
Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-024-45306-y Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-45306-y
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-024-45306-y
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().